With the fairly recent DQSA (Drug Quality and Security Act), plus new regulations in China for GSP, and the EU for GDP, plus rumors that Japan will be adopting the EU GDP guidelines, it seems that global regulations are becoming harmonized. These regulations are based upon quality, risk mitigation, and the measures taken to prevent adulteration or the counterfeiting of drugs.